Sunday, 26 September 2021


Indonesia deploys dedicated oxygen facility for COVID-19 patients

19 July 2021 | News

"Gotong Royong Oxygen House" to be set up in collaboration with KADIN Indonesia and Samator Group

Photo Credit: PRNewswire

Photo Credit: PRNewswire

In response to Indonesia's current COVID-19 oxygen crisis, a consortium led by the GoTo Group is set to create the country's first 'oxygen house' - a facility that will provide an ongoing oxygen supply to people suffering from COVID-19.

The initiative, known as The Gotong Royong (Hand-in-hand) Oxygen House, is being carried out by GoTo in partnership with the Indonesian Chamber of Commerce and Industry (KADIN Indonesia), the Samator Group, and a number of government agencies.

The facility, located in Pulogadung in East Jakarta, will be able to provide an ongoing, uninterrupted oxygen supply for COVID sufferers as the gas will be piped directly from the Samator Group's oxygen production plant located nearby. It is the first semi-permanent health facility in Indonesia equipped with oxygen supply equipment and beds to support those exposed to COVID-19 with moderate symptoms who need temporary oxygen relief.

The project is expected to help reduce the Bed Occupancy Rate (BOR) of hospitals in Jakarta, which has reached 85%. If there are any patients who are being treated at the Oxygen House whose condition deteriorates, they can quickly be referred to one of the COVID-19 referral hospitals, several of which are located in the vicinity.

Andre Soelistyo, CEO of GoTo said, "The facility will provide an ongoing supply of oxygen to those who need it the most - it will save lives and alleviate suffering for many people in the city. No one should have to suffer due to a lack of oxygen and we are determined to work with government and private sector partners to play a role in helping to alleviate this national problem."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account